COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections

J Infect. 2022 May;84(5):722-746. doi: 10.1016/j.jinf.2022.01.033. Epub 2022 Jan 31.

Authors

Camilla Mattiuzzi¹, Giuseppe Lippi²

Affiliations

¹ Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy.
² Section of Clinical Biochemistry and School of Medicine, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy. Electronic address: giuseppe.lippi@univr.it.

No abstract available

Keywords: COVID-19; Infection; SARS-CoV-2; Vaccination.

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
BNT162 Vaccine